| 000 | 01464 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515033505.0 | ||
| 264 | 0 | _c20060808 | |
| 008 | 200608s 0 0 rus d | ||
| 022 | _a1997-7298 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSapary, L | |
| 245 | 0 | 0 |
_a[Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients]. _h[electronic resource] |
| 260 |
_bZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _c2006 |
||
| 300 |
_a47-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aBlood Viscosity _xdrug effects |
| 650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xblood |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aErythrocyte Aggregation _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVinca Alkaloids _xadministration & dosage |
| 700 | 1 | _aHorvath, B | |
| 700 | 1 | _aAlexy, T | |
| 700 | 1 | _aMarton, Zs | |
| 700 | 1 | _aKesmarky, G | |
| 700 | 1 | _aZsots, M | |
| 700 | 1 | _aNagy, F | |
| 700 | 1 | _aCzopf, I | |
| 700 | 1 | _aToth, K | |
| 773 | 0 |
_tZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _gvol. 106 _gno. 6 _gp. 47-51 |
|
| 999 |
_c16432297 _d16432297 |
||